These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24346811)

  • 61. [Case of schizophrenia in which depressive and negative symptoms relapsed on switching from oral risperidone to risperidone long-acting injection].
    Mori T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):977-82. PubMed ID: 22187885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.
    Yoon KS; Park TW; Yang JC; Kim MG; Oh KY; Park MS; Chung YC
    Hum Psychopharmacol; 2012 May; 27(3):305-14. PubMed ID: 22585590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Treatment with paliperidone extended-release tablets in a case of resistant undifferentiated schizophrenia: clinical improvement with 12 mg and evaluation through 3TRE scale].
    Rusconi AC; Carlone C; Muscillo M; Piccione M
    Riv Psichiatr; 2009; 44(4):267-72. PubMed ID: 20066799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.
    Jones MP; Nicholl D; Trakas K
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):383-99. PubMed ID: 20497747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats.
    Marchese G; Pittau B; Casu G; Peddio G; Spada GP; Pira M; Deriu A; Portesani F; Pisu C; Lazzari P; Pani L
    Eur Psychiatry; 2010 Mar; 25(2):92-100. PubMed ID: 19640686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study.
    Schmauss M; Jukić V; Siracusano A; Bidzan L; Badescu GM; Maciulis V; Lahaye M; Hoeben D; Tessier C; Schreiner A
    Curr Med Res Opin; 2012 Aug; 28(8):1395-404. PubMed ID: 22746355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Paliperidone--a novel second-generation antipsychotic].
    Maknyte K; Lublin HK
    Ugeskr Laeger; 2008 Aug; 170(35):2679-81. PubMed ID: 18761856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents.
    Singh J; Robb A; Vijapurkar U; Nuamah I; Hough D
    Biol Psychiatry; 2011 Dec; 70(12):1179-87. PubMed ID: 21831359
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
    Knegtering R; Baselmans P; Castelein S; Bosker F; Bruggeman R; van den Bosch RJ
    Am J Psychiatry; 2005 May; 162(5):1010-2. PubMed ID: 15863810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.
    Gefvert O; Eriksson B; Persson P; Helldin L; Björner A; Mannaert E; Remmerie B; Eerdekens M; Nyberg S
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):27-36. PubMed ID: 15710053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The pharmacokinetics of paliperidone versus risperidone.
    de Leon J; Wynn G; Sandson NB
    Psychosomatics; 2010; 51(1):80-8. PubMed ID: 20118446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone.
    Perry R; Wolberg J; DiCrescento S
    Am J Health Syst Pharm; 2012 Jan; 69(1):40-3. PubMed ID: 22180550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risperidone: effects of formulations on oral bioavailability.
    Gutierrez R; Lee PI; Huang ML; Woestenborghs R
    Pharmacotherapy; 1997; 17(3):599-605. PubMed ID: 9165565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
    Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM
    Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia.
    Suzuki H; Gen K; Otomo M; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):76-82. PubMed ID: 23438159
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paliperidone for treatment of schizophrenia.
    Nussbaum AM; Stroup TS
    Schizophr Bull; 2008 May; 34(3):419-22. PubMed ID: 18375569
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment with paliperidone in children with behavior disorders previously treated with risperidone: an open-label trial.
    Fernández-Mayoralas DM; Fernández-Jaén A; Muñoz-Jareño N; Calleja-Pérez B; Fernández-Perrone AL; Arribas SL
    Clin Neuropharmacol; 2012; 35(5):227-30. PubMed ID: 22935606
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia.
    Zhou ZL; Li X; Peng HY; Yu XY; Yang M; Su FL; Wang F; Zhu RH; Deng CY; Lin QX; Wang CY; Li WB; Lin SG; Li HD
    Acta Pharmacol Sin; 2006 Mar; 27(3):381-6. PubMed ID: 16490177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.